Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments targeting specific cells often cause skin problems, which can affect how much medicine patients can take.

Cancer drugs often cause temporary hair, skin, nail, and mouth issues.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Most pediatric cancer patients in the study developed skin problems, often due to their cancer treatment.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Using stem cells from fat tissue can significantly improve wound healing in dogs.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Mannitol diuresis allows higher doses of cis-platinum for testicular cancer treatment without increasing kidney damage.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

A liquid protein diet caused hair loss in a young woman.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Histone modification is key in treating chronic inflammatory skin diseases.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

PLD is an effective and safer alternative for treating breast cancer.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Fluconazole is an effective antifungal medication with potential side effects and lacks official analytical methods for its determination.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

The document concludes that validated methods are needed to ensure the quality of fluconazole drugs and that new antifungal medications are necessary due to safety and resistance concerns.